Mosseri Marlio Charles — SEC Form 4 filings
SEC reporting owner CIK 1806384. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-12-16 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 26 legs across 10 filings — 626,176 shares, $4,350,799 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 240,000 shares @ $5.00 ($1,200,000) in Nuvectis Pharma, Inc., filed 2025-02-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | 10% owner | 10 | 26 legs · 626,176 sh · $4,350,799 | — | — |
Form 4 filings — Mosseri Marlio Charles
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 50,000 @ $18.32 | EDGAR |
| 2025-10-29 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 46,900 @ $6.06 · Purchase (P): 35,034 @ $6.15 · Purchase (P): 72,836 @ $6.28 | EDGAR |
| 2025-06-24 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 5,603 @ $7.99 | EDGAR |
| 2025-06-20 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 5,399 @ $8.11 · Purchase (P): 28,043 @ $8.05 | EDGAR |
| 2025-05-13 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 21,167 @ $8.11 | EDGAR |
| 2025-05-12 | 4/A | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 100 @ $8.99 · Purchase (P): 100 @ $8.71 · Purchase (P): 2,400 @ $8.97 · Purchase (P): 9,850 @ $8.95 · Purchase (P): 9,817 @ $8.90 · Purchase (P): 5,395 @ $8.98 | EDGAR |
| 2025-05-09 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 2,340 @ $8.40 · Purchase (P): 10,104 @ $8.64 · Purchase (P): 2,703 @ $8.40 · Purchase (P): 9,614 @ $8.64 · Purchase (P): 50 @ $8.65 · Purchase (P): 100 @ $8.65 · +2 more | EDGAR |
| 2025-02-11 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 240,000 @ $5 | EDGAR |
| 2024-12-16 | 4/A | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 32,121 @ $4.64 · Purchase (P): 17,000 @ $4.70 | EDGAR |
| 2024-12-16 | 4 | Nuvectis Pharma, Inc. (NVCT) | Purchase (P): 17,000 @ $4.70 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1806384 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →